[Baltimore, MD] - [11/12/2024] – NomadX is pleased to announce that Dr. Christopher Ellis has joined the company as Chief Scientific Officer. In his new role, Dr. Ellis will guide the scientific direction of NomadX, leveraging his extensive experience in drug discovery, AI/machine learning, and multi-omic analysis to propel the company's research and development initiatives.

Dr. Ellis arrives at NomadX with over two decades of experience in the biomedical research field. He has a remarkable track record of contributions to the development of blockbuster drugs, and has earned a reputation for grant funding success, and scientific publications.

Prior to joining NomadX, Dr. Ellis cofounded a company where he spearheaded initiatives focused on neurodegenerative and endocrine diseases. His leadership was pivotal in advancing large-scale NGS projects, developing AI-driven platforms, and establishing strategic partnerships. Dr. Ellis's expertise extends to managing virtual screening across various drug discovery modalities, enhancing small molecule, monoclonal antibody, and peptide drug discovery processes. His technical acumen and visionary approach to AI and machine learning have consistently driven innovation and operational success across numerous research institutions and companies.

"I am thrilled to join NomadX as Chief Scientific Officer and lead our scientific strategy towards successful commercialization," said Dr. Ellis. "This is an exciting opportunity to drive cutting-edge innovation that advances detection technology and enhances global safety. I look forward to collaborating with the talented team at NomadX and turning visionary research into impactful real-world solutions."

Dr. Ellis's appointment signals a significant step forward for NomadX as it seeks to strengthen its leadership in the pathogen detection industry, delivering on its commitment to quality, innovation, and global food safety.

About NomadX

NomadX is a pioneering leader in the pathogen detection industry, dedicated to advancing detection technologies and enhancing global safety. With a focus on innovation, NomadX is committed to transforming visionary research into real-world solutions that drive positive change. For further information, visit www.nomadxholdings.com.

Contact Information

Jennifer Williams

Chief Operating Officer

NomadX

646-589-3800

[email protected]